Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Julio César García Casallas has a total of 89 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    New Insights in blaKPC Gene Mobilization in Pseudomonas aeruginosa: Acquisition of blaKPC-3 and Identification of a New Tn2-like NTE Mobilizing blaKPC-2

    by Deisy Abril, Juan Bravo-Ojeda, Julio-Cesar Garcia, Aura Lucia Leal-Castro, Carlos Humberto Saavedra-Trujillo, Johana Madroñero, Rosa-Helena Bustos, Ricaurte Alejandro Marquez-Ortiz, Zayda Lorena Corredor Rozo, Natasha Vanegas Gómez, et al.

    Carbapenem-resistant Pseudomonas aeruginosa is a major cause of healthcare associated infections in hospitalized patients and what is more warring with reduced therapeutic options. The KPC is a powerful enzyme capable of hydrolyzing the carbapenems, described first in Klebsiella pneumoniae and it already has found in P. aeruginosa.Objective: To perform a comparative genomic analysis of two new genetic platforms mobilizing the blaKPC-2 and blaKPC-3 in two ST111 and ST235 pandemic clones of P. aeruginosa in Colombia, South America. Methods: Sixty-six blaKPC-harboring P. aeruginosa isolates were identified and characterized during a prospective study conducted in six high complex hospitals in Colombia. Genetic platforms mobilizing the blaKPC were analyzed. Results: The blaKPC-2 and blaKPC-3 were identified in 24 and 42 isolates, respectively. The blaKPC-2-harboring isolates belonged to ST235 and blaKPC-3 to ST111. The whole genome sequencing indicated that the blaKPC-3 gene was mobilized by the Tn4401b within a 55-kb-size environmental origin plasmid, which, in other isolates, was inserted into the chromosome through a transposition event of ISPa38. Regarding the blaKPC-2 gene, this was mobilized by a new Non-Tn4401 Element (NTE) derived from transposon Tn2 (proposed as variant IIg), which has been transposed into a 43-Kb-size little-studied plasmid related to Klebsiella spp. Conclusions: Our results reveal a new acquisition event of blaKPC in P. aeruginosa, in this case blaKPC-3. Likewise, the pandemic high-risk clones ST111 and ST235 of P. aeruginosa continues to spread blaKPC gene through different mobile genetic elements, jumping of conventional Tn4401b and acquiring new Tn2-derived NTE, which were inserted in diverse plasmids.


  • Open Access

    Breaking Barriers: Integrating Nanotechnology and Nanomedicine into Medical Specialty Education

    by Mónica María Díaz-López, Rosa-Helena Bustos, Julio-Cesar Garcia, Juan Francisco Guevara-Ramírez

    Background: Nanotechnology has emerged as a promising field of study, aiming to revolutionize healthcare through the innovative development of drugs, diagnostic tools, and medical devices. As a result, healthcare professionals in training are constantly faced with the challenge of understanding and applying these emerging technologies. The objective of this study is to determine the factors to consider for including the teaching of nanotechnological tools in medical specialty postgraduate programs. Methods: A study based on the Nominal Group Technique (NGT) was conducted to identify the factors that promote and hinder the implementation of nanotechnology in certain postgraduate programs where nanotechnology is employed, such as Internal Medicine, Critical Care Medicine, Family Medicine, and Clinical Pharmacology at the School of Medicine of Universidad de La Sabana. A framework analysis was used to analyze the collected data. Results: Based on the two research questions, several aspects were identified for the inclusion of nanotechnology in the medical practice of specialties. Key challenges include lack of knowledge and resource availability, misinformation, and lack of knowledge, as well as paradigmatic analysis as the main obstacles to the use of nanotechnology. Conclusions: The findings provide a first-time study on nanotechnology curricula within medical specialty programs in Colombia, with potential extrapolation to similar situations in other medical schools.


  • Open Access

    Bootcamps para el desarrollo de competencias clínicas en estudiantes de Medicina durante la pandemia por COVID-19

    by María José Maldonado, Daniel Upegui Mojica, Julio García-Casallas, Sergio Agudelo-Pérez

  • Open Access

    Caracterización sociodemográfica del trauma maxilofacial en un centro de tercer nivel de complejidad en Chía, Colombia

    by José Antonio Vélez Serna, Julio Cesar García Casallas, Luis Ángel Nieto Vargas, Luisa Fernanda Cogua Martinez, Melanie Alejandra Pérez Orbegozo

    Introduction: Maxillofacial trauma is considered a surgical emergency when associated with cranioencephalic trauma (CET). The most important demographic findings will be described in a group of patients selected for the present study. To describe the sociodemographic and clinical characteristics of patients diagnosed with maxillofacial trauma, as well as to determine the main treatment and stabilization guidelines developed in a third level complexity center in the township of Chía in Colombia.Materials and methods: This is a observational and descriptive study, developed by the Department of Clinical Pharmacology and Maxillofacial Surgery to characterize the demographic population with maxillofacial trauma at the Clínica de la Universidadde La Sabana. Results: We analyzed 37 patients in the present study, with an average age of 35 years, finding a higher incidence of presentation in the male gender. Among the most frequent causes; in 56% of cases, traffic events are recorded as a motorcycle driver. Within the classification of fractures, panfacial’s fractures were found in 24.4% of the cases, being the most prevalent. In the hospital setting, 43% of patients had severe CET. The waiting time to perform a surgical intervention was approximately 3.8 days. Finally, management requirements were defined in the Intensive Care Unit (ICU) through 5 variables such as: use of vasopressors, sedation, analgesics, gastrostomy or tracheostomy and additional management in ICU

  • Open Access

    Liver abscess due to Granulicatella adiacens in an immunocompetent patient: Case report

    by Julio García-Casallas, Katherine Patiño-Salazar, Eduardo Tuta-Quintero, Miguel Molina-Ardila

    Pyogenic liver abscesses due to Granulicatella adiacens are infections associated with high mortality, mainly in immunocompromised patients. The main microorganisms associated with liver abscesses are Klebsiella pneumoniae, and Escherichia coli, though it may also be polymicrobial. However, case reports describing liver infection by Granulicatella adiacens are scarce.We present the case of an immunocompetent adult patient who presented 15 days of evolution consisting of quantified fever peaks associated with asthenia, adynamia, chills, jaundice and coluria. The initial clinical examination revealed a generalized icteric tint without abdominal pain, and blood pressure with a tendency to hypotension. Biliopancreatic confluent neoplasia, secondary cholangitis and sepsis of biliary origin were suspected, initiating fluid resuscitation and antibiotic therapy; blood cultures and complementary diagnostic studies were taken. Hepatobiliary ultrasound with evidence of an abscess of 73 x 62 mm in segment IV; the bile duct and pancreas were within normal limits. To better characterize the lesion evidenced in the liver, a contrast-enhanced computed tomography of the abdomen was performed. The patient completed antibiotic management with ciprofloxacin, vancomycin, and metronidazole in good condition and was successfully discharged.This is the first pyogenic liver abscess reported caused by Granulicatella adiacens in an immunocompetent patient, in whom early microbiological diagnosis in conjunction with targeted antibiotic treatment and percutaneous drainage of the lesion was decisive in the clinical outcome.


  • Open Access

    Implementing Vancomycin Population Pharmacokinetic Models: An App for Individualized Antibiotic Therapy in Critically Ill Patients

    by Manuel Mena, Julio-Cesar Garcia, Rosa-Helena Bustos

    In individualized therapy, the Bayesian approach integrated with population pharmacokinetic models (PopPK) for predictions together with therapeutic drug monitoring (TDM) to maintain adequate objectives is useful to maximize the efficacy and minimize the probability of toxicity of vancomycin in critically ill patients. Although there are limitations to implementation, model-informed precision dosing (MIPD) is an approach to integrate these elements, which has the potential to optimize the TDM process and maximize the success of antibacterial therapy. The objective of this work was to present an app for individualized therapy and perform a validation of the implemented vancomycin PopPK models. A pragmatic approach was used for selecting the models of Llopis, Goti and Revilla for developing a Shiny app with R. Through ordinary differential equation (ODE)-based mixed effects models from the mlxR package, the app simulates the concentrations’ behavior, estimates whether the model was simulated without variability and predicts whether the model was simulated with variability. Moreover, we evaluated the predictive performance with retrospective trough concentration data from patients admitted to the adult critical care unit. Although there were no significant differences in the performance of the estimates, the Llopis model showed better accuracy (mean 80.88%; SD 46.5%); however, it had greater bias (mean −34.47%, SD 63.38%) compared to the Revilla et al. (mean 10.61%, SD 66.37%) and Goti et al. (mean of 13.54%, SD 64.93%) models. With respect to the RMSE (root mean square error), the Llopis (mean of 10.69 mg/L, SD 12.23 mg/L) and Revilla models (mean of 10.65 mg/L, SD 12.81 mg/L) were comparable, and the lowest RMSE was found in the Goti model (mean 9.06 mg/L, SD 9 mg/L). Regarding the predictions, this behavior did not change, and the results varied relatively little. Although our results are satisfactory, the predictive performance in recent studies with vancomycin is heterogeneous, and although these three models have proven to be useful for clinical application, further research and adaptation of PopPK models is required, as well as implementation in the clinical practice of MIPD and TDM in real time.


  • Open Access

    Actividades profesionales a confiar: hacia una estandarización del lenguaje y significado en español y portugués

    by Marcus Vinicius Melo de Andrade, María José López, Luis Carlos Domínguez Torres, Verónica Daniela Durán Pérez, Eduardo Durante, Samuel Eloy Gutiérrez Barreto, Manuel Eduardo Gutiérrez Sierra, Julio César García Casallas, Ieda Francischetti, Isabel Eugenia Mora Melanchthon, et al.

    El enfoque de EPAs ha tenido un gran impacto en la educación médica desde que surgió en 2005. Su difusión a través de diferentes regiones del mundo ha requerido traducción a varios idiomas, y en algunas ocasiones ha generado confusiones terminológicas y de significado. Este artículo es el resultado de un consenso respecto de la traducción de términos clave para la comprensión del enfoque en español y portugués. Se llevó a cabo a través de un proceso de análisis de significado de cada término en el contexto idiomático y de la realidad de la formación de profesionales de la salud en Latinoamérica. Estuvo a cargo de doce profesionales, docentes y académicos involucrados en la implementación y formación con EPAs en ocho países, que formaron parte como responsables, facilitadores o participantes del International Course Ins and Outs of EPAs 2021 para Latinoamérica.


  • Open Access

    Criptococosis diseminada por terapia biológica, se debe gestionar el riesgo

    by Efraín Guillermo Sánchez, David Acosta, Juan Álvarez, Gabriela Sánchez, Julio García-Casallas

    Introducción. Se han descrito múltiples efectos adversos con el uso de la terapia biológica para enfermedades autoinmunitarias, muchos de ellos secundarios al estado de inmunosupresión, como las infecciones bacterianas, fúngicas o virales.Caso clínico. Se presenta el caso de una mujer de 64 años con diagnóstico comprobado de criptococosis diseminada secundaria al uso de tofacitinib. Se descartaron otras causas de inmunosupresión, como infección por el virus de la inmunodeficiencia humana (HIV). Tres años antes se le había diagnosticado artritis reumatoide y se encontraba en tratamiento farmacológico con un agente biológico que inhibe las enzimas JAK. Se han descrito muy pocos casos de criptococosis pulmonar y meníngea en este tipo de pacientes. Conclusión. Este reporte de caso es útil para que otros médicos tratantes tengan presente la posibilidad de este tipo de infección fúngica invasora asociada con la terapia biológica y el enfoque de gestión de riesgo.


  • Open Access

    Estimation of the Difference in Colistin Plasma Levels in Critically Ill Patients with Favorable or Unfavorable Clinical Outcomes

    by Jose Sanabria, Vivian Garzón, Tatiana Pacheco, Maria-Paula Avila, Julio-Cesar Garcia, Diego Jaimes, Angela Torres, Rosa-Helena Bustos, Javier Escobar-Perez, Deisy Abril

    In recent decades, antimicrobial resistance (AMR) has led to an increased use of therapeutic alternatives. Among these options, colistin continues to be an option for the treatment of multi-resistant (MDR) Gram-negative bacterial infections. However, due to its high toxicity (nephrotoxicity and neurotoxicity) and narrow therapeutic window, colistin treatment must be utilized carefully. Colistin-treated patients have been observed to have higher mortality due to inadequate therapeutic levels. The objective of this study was to estimate the difference in colistin plasma levels in critically ill patients, and its relationship to favorable or unfavorable clinical outcomes. This prospective observational study was conducted between September 2017 and June 2020 at the Universidad de La Sabana Clinic, in patients who had been treated with colistimethate sodium (CMS) for at least 72 h until day 7 of drug treatment in the critical care unit of a university hospital. There were no statistically significant differences in colistin levels between groups with favorable or unfavorable clinical outcomes (0.16 SD vs. 0.54 SD p-value = 0.167). There was higher mortality in patients with subtherapeutic levels (18% vs. 0%), and additionally, there was a greater rate of renal failure in the group with higher therapeutic levels (50% vs. 20.7%). Due to the loss of power of the study, we were unable to demonstrate a possible difference between colistin levels related to favorable or unfavorable clinical outcomes at day 7. However, we recommend further studies to evaluate the impact of measuring levels in terms of mortality and security.


  • Open Access

    Is There a Role for the Therapeutic Drug Monitoring of Colistin? An Overview

    by Maria-Paula Avila, Tatiana Pacheco, Sara Arias, Rosa-Helena Bustos, Julio-Cesar Garcia, Diego Jaimes

    Colistin is used as a last-line antibiotic for the treatment of Gram-negative multiresistant bacteria. Due to its high nephrotoxicity, Therapeutic Drug Monitoring (TDM) is recommended for dose adjustment. We aimed to evaluate the available evidence of TDM in patients given colistin to treat Gram-negative infections. In this paper, we offer an overview, using an electronic search of the literature (published up to June 2019, without language restrictions) that compares the clinical outcomes and measurements of colistin TDM. Ultimately, the Therapeutic Drug Monitoring (TDM) of colistin in Plasma could prevent nephrotoxicity risk.